IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.09-3434 on April 8, 2009
(Investigative Ophthalmology and Visual Science. 2009;50:4288-4294.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.09-3434

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.09-3434v1
50/9/4288    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagkalis, A.
Right arrow Articles by Crane, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagkalis, A.
Right arrow Articles by Crane, I. J.

Development of Experimental Autoimmune Uveitis: Efficient Recruitment of Monocytes Is Independent of CCR2

Athanasios Dagkalis,1 Carol Wallace,1 Heping Xu,1 Sebastian Liebau,1 Ayyakkannu Manivannan,1 Michael A. Stone,2 Matthias Mack,3 Janet Liversidge,1 and Isabel J. Crane1

1From the Division of Applied Medicine, University of Aberdeen, Aberdeen, United Kingdom; 2Respiratory and Inflammation Research, AstraZeneca, Cheshire, United Kingdom; and the 3Department of Internal Medicine II, University of Regensburg, Regensburg, Germany.

PURPOSE. Macrophages are major contributors to the damage occurring in the retina in experimental autoimmune uveitis (EAU). CCR2 may be needed for efficient recruitment of monocytes to an inflammatory site, and the aim of this study was to determine whether this was the case in EAU.

METHODS. EAU was induced and graded in C57BL/6J and CCR2–/– mice. Macrophage infiltration and CCR2 expression were assessed using immunohistochemistry. Retinas were examined for MCP-1 expression using RT-PCR. Rolling and infiltration of labeled bone marrow monocytes at the inflamed retinal vasculature were examined by scanning laser ophthalmoscopy and confocal microscopy, respectively. Effect of CCR2 deletion or blockade by antibody and antagonist was determined.

RESULTS. Expression of mRNA for MCP-1 increased as EAU developed and was localized to the retina. CCR2 was associated with infiltrating macrophages. However, EAU induced in CCR2–/– mice was not reduced in severity, and neither was the percentage of macrophages in the retina. CCR2–/– monocytes, 48 hours after adoptive transfer to mice with EAU, showed no significant difference in percentage rolling or infiltration into the retina compared to WT. CCR2-independent rolling of monocytes was confirmed by CCR2 neutralizing antibody and antagonist treatment.

CONCLUSIONS. CCR2 does not have a primary role in the recruitment of monocytes to the inflammatory site across the blood–retina barrier in well-developed EAU. Therapeutics targeting CCR2 are unlikely to be of value in treating human posterior uveitis.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology